AlgovestIQCatalysts
Earnings · Growth Drivers · Events · AIQ Catalyst
Healthcare / Medical - Diagnostics & Research
Low Priority
In Line With Peers
Latest quote
Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.
Upcoming reporting date available for this company.
Momentum 82/100 and sentiment — before the next covered event.
Updated Oct 30, 2026 · Sentiment 60.17%
See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.
Compare what analysts expected with what the company reported across recent quarters.
| Report date | Fiscal period | EPS estimate | EPS actual | EPS surprise | Revenue estimate | Revenue actual |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | — | $6.40 | — | — | $11.95B | — |
| Oct 21, 2026 | — | $6.40 | $6.68 | +4.4% | $11.95B | $12.14B |
| Jul 23, 2026 | — | $5.72 | $6.03 | +5.4% | $11.71B | $11.99B |
| Apr 23, 2026 | — | $5.25 | $5.44 | +3.6% | $10.86B | $11.01B |
| Jan 29, 2026 | — | $6.45 | $6.57 | +1.9% | $11.95B | $12.22B |
Wall Street consensus, rating distribution, and the current 12-month target range.
Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.
Current event setup
Next known earnings or reporting date.
Current analyst expectation for the upcoming report.
Current analyst expectation for the upcoming report.
News pressure around the setup.
Where event reaction would show up first.
Composite decision read before event confirmation.
Analyst context
Recent company coverage, scored where source sentiment is available.
Young innovators awarded more than $100,000 for research on dementia-related proteins, alternatives to agricultural plastics and wildfire prevention
Revenue: Q3 revenue grew 9% to $12.14 billion; organic growth 6%, acquisitions contributed 4%, microbiology divestiture reduced 1%.Adjusted Operating Income: Gr
Related Links
TMO Catalysts FAQ
TMO's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.
Upcoming events that could move TMO include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.
TMO's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.
TMO could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.
TMO could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.